Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-01 @ 6:30 AM
Study NCT ID:
NCT06311851
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2024-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Sponsor:
Pardis Noor Medical Imaging and Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PNCC140201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None